What is it about?
In this randomized clinical trial, we showed standard CXL offered better anterior corneal flattening in the center and periphery. Two protocols were similarly effective in central cases but not in peripheral KCN. This difference was clinically negligible between two groups.
Featured Image
Why is it important?
Our findings show that the accelerated CXL can be used as alternative protocol in treatment of progressive KCN.
Perspectives
I hope this article makes surgeons to think about standard CXL alternatives.
Soheila Asgari
Noor Eye Hospital
Read the Original
This page is a summary of: Standard and accelerated corneal cross-linking long-term results: A randomized clinical trial, European Journal of Ophthalmology, April 2019, SAGE Publications,
DOI: 10.1177/1120672119839927.
You can read the full text:
Contributors
The following have contributed to this page
